Nearmap is chewing money … capture costs alone for FY18 13,5 million for revenue of 10.5 million Unamortised capture costs 27.9 million and growing
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor